全文获取类型
收费全文 | 1639篇 |
免费 | 230篇 |
出版年
2021年 | 23篇 |
2020年 | 14篇 |
2019年 | 20篇 |
2018年 | 21篇 |
2017年 | 20篇 |
2016年 | 41篇 |
2015年 | 43篇 |
2014年 | 43篇 |
2013年 | 81篇 |
2012年 | 70篇 |
2011年 | 69篇 |
2010年 | 52篇 |
2009年 | 38篇 |
2008年 | 70篇 |
2007年 | 80篇 |
2006年 | 72篇 |
2005年 | 57篇 |
2004年 | 51篇 |
2003年 | 46篇 |
2002年 | 47篇 |
2001年 | 54篇 |
2000年 | 38篇 |
1999年 | 40篇 |
1998年 | 28篇 |
1997年 | 16篇 |
1996年 | 23篇 |
1995年 | 23篇 |
1994年 | 21篇 |
1993年 | 17篇 |
1992年 | 43篇 |
1991年 | 35篇 |
1990年 | 34篇 |
1989年 | 42篇 |
1988年 | 34篇 |
1987年 | 40篇 |
1986年 | 29篇 |
1985年 | 38篇 |
1984年 | 24篇 |
1983年 | 29篇 |
1982年 | 22篇 |
1980年 | 13篇 |
1979年 | 17篇 |
1978年 | 12篇 |
1977年 | 20篇 |
1976年 | 11篇 |
1975年 | 17篇 |
1973年 | 11篇 |
1971年 | 14篇 |
1969年 | 11篇 |
1967年 | 10篇 |
排序方式: 共有1869条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
Shelley Gorman Clare E. Weeden Daryl H. W. Tan Naomi M. Scott Julie Hart Rachel E. Foong Danny Mok Nahiid Stephens Graeme Zosky Prue H. Hart 《PloS one》2013,8(6)
Vitamin D may be essential for restricting the development and severity of allergic diseases and asthma, but a direct causal link between vitamin D deficiency and asthma has yet to be established. We have developed a ‘low dose’ model of allergic airway disease induced by intraperitoneal injection with ovalbumin (1 µg) and aluminium hydroxide (0.2 mg) in which characteristics of atopic asthma are recapitulated, including airway hyperresponsiveness, antigen-specific immunoglobulin type-E and lung inflammation. We assessed the effects of vitamin D deficiency throughout life (from conception until adulthood) on the severity of ovalbumin-induced allergic airway disease in vitamin D-replete and -deficient BALB/c mice using this model. Vitamin D had protective effects such that deficiency significantly enhanced eosinophil and neutrophil numbers in the bronchoalveolar lavage fluid of male but not female mice. Vitamin D also suppressed the proliferation and T helper cell type-2 cytokine-secreting capacity of airway-draining lymph node cells from both male and female mice. Supplementation of initially vitamin D-deficient mice with vitamin D for four weeks returned serum 25-hydroxyvitamin D to levels observed in initially vitamin D-replete mice, and also suppressed eosinophil and neutrophil numbers in the bronchoalveolar lavage fluid of male mice. Using generic 16 S rRNA primers, increased bacterial levels were detected in the lungs of initially vitamin D-deficient male mice, which were also reduced by vitamin D supplementation. These results indicate that vitamin D controls granulocyte levels in the bronchoalveolar lavage fluid in an allergen-sensitive manner, and may contribute towards the severity of asthma in a gender-specific fashion through regulation of respiratory bacteria. 相似文献
8.
G W Stephens W Lieberthal N B Oza C R Valeri N G Levinsky 《Renal physiology and biochemistry》1988,11(1-2):50-59
We have found that arginine vasopressin (AVP) (10 pg/ml) stimulates urinary kallikrein in the isolated erythrocyte perfused rat kidney. (In this model, perfusate flow rate approximates blood flow rates in vivo and morphology is normal.) Urinary kallikrein excretion rose from 6.9 +/- 0.8 to 14.9 +/- 2.4 ng/min 20 min after the addition of AVP to the perfusate, and then fell towards baseline levels over the next 30 min. 1-Desamino-8-D-AVP (8 pg/ml) caused a comparable increase in kallikrein excretion. Prostaglandin synthesis inhibition with indomethacin did not alter the stimulatory effect of AVP on kallikrein excretion. Parathyroid hormone 1-34 (144 ng/ml) and calcitonin (102 ng/ml) also increased urinary kallikrein. Kallikrein excretion rose from 9.1 +/- 2.0 to 24 +/- 4.5 ng/min in response to calcitonin and from 8.3 +/- 1.6 to 43.7 +/- 3.4 ng/min following the addition of parathyroid hormone to the perfusate. Kallikrein was found to accumulate in the perfusate in a linear fashion. Based on the slope of the relationship between perfusate kallikrein and time, the rate of release of kallikrein into the perfusate was estimated to be 0.79 ng/min in control kidneys. The rate of release of kallikrein into the perfusate in kidneys treated with AVP was the same (0.74 ng/min). Thus while kallikrein is released into the perfusate, this process is not influenced by AVP. In conclusion, AVP stimulates release of kallikrein into the urine (but not the perfusate) independently of systemic events. The effect of AVP is not mediated by prostaglandins. This effect of AVP is mediated via stimulation of the V2 receptor and also occurs in response to two other hormones (calcitonin and parathyroid hormone) that are known to stimulate adenyl cyclase in the rat distal nephron. 相似文献
9.
Peter J Stephens 《BMJ (Clinical research ed.)》2005,330(7506):1508-1509
10.